UBS Group AG - ALLIQUA BIOMEDICAL INC ownership

ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 36 filers reported holding ALLIQUA BIOMEDICAL INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALLIQUA BIOMEDICAL INC
ValueSharesWeighting
Q1 2017$7,000
+133.3%
12,955
+156.9%
0.00%
Q4 2016$3,0000.0%5,043
+28.4%
0.00%
Q3 2016$3,000
+50.0%
3,928
+142.9%
0.00%
Q2 2016$2,0001,617
+609.2%
0.00%
Q1 2016$0
-100.0%
228
-81.4%
0.00%
Q4 2015$2,000
+100.0%
1,223
+436.4%
0.00%
Q3 2015$1,000
-95.0%
228
-94.1%
0.00%
Q2 2015$20,000
+185.7%
3,868
+183.4%
0.00%
Q1 2015$7,000
+600.0%
1,365
+498.7%
0.00%
Q4 2014$1,0002280.00%
Other shareholders
ALLIQUA BIOMEDICAL INC shareholders Q1 2016
NameSharesValueWeighting ↓
Perceptive Advisors 784,594$6,472,0000.68%
J. Goldman & Co LP 510,000$4,299,0000.32%
SUFFOLK CAPITAL MANAGEMENT LLC 186,287$1,570,0000.20%
JHL Capital Group LLC 80,000$674,0000.05%
Edge Wealth Management LLC 4,930$42,0000.02%
PRELUDE CAPITAL MANAGEMENT, LLC 5,000$42,0000.01%
MILLENNIUM MANAGEMENT LLC 100,000$843,0000.00%
Tower Research Capital LLC (TRC) 1,671$14,0000.00%
Family Capital Trust Co 200$2,0000.00%
MORGAN STANLEY 5,979$50,0000.00%
View complete list of ALLIQUA BIOMEDICAL INC shareholders